SHANGHAI, China, Nov. 22, 2022 (GLOBE NEWSWIRE) — Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced today that the supplemental application for additional indications of adalimumab injection (project code: UBP1211, trade

VILNIUS, Lithuania, Nov. 21, 2022 (GLOBE NEWSWIRE) — With 12 years of market experience under its belt already, Locatory.com is not slowing down. The aviation marketplace for aircraft spare parts and repair capabilities and a family member of Avia Solutions Group, leaders in end-to-end capacity solutions for passenger and cargo